Home page

#1 Brand names

Sites parents

Brand name

Information about Abbott Laboratories brand name. This is a page presenting information about Abbott Laboratories brand name on Visiobrand - the biggest brand directory in the Internet. Visiobrand has selected Abbott Laboratories brand name and registered Abbott Laboratories links manually in its directory. All the information about Abbott Laboratories presented on the Visiobrand site is only verified information from the official Abbott Laboratories source.

This is the VisioBrand's cache of http://www.abbott.com/global/url/pressReleases/en_US/60.5:5/general_content/Press_Release_Selector_01.htm?filterType=none. The page may have been changed since the time we've created the cache.
Click here for the current version of the page.

Please also find related categories of brand names on VisioBrand catalogue:
Nutrition, Weight Loss (56)
Health, Medical Services (329)
Medicine (227)
Other Health, Medical Services (10)

Membership
VisioBrand has a free membership account where you can take advantages of special services such as adding Abbott Laboratories brand name to your favourite brands list to be able to quickly find them and learn what’s new.

Submit information on Abbott Laboratories If you want us to feature some special links to Abbott Laboratories official site, please contact us.

VisioBrand - Official Site - Abbott Laboratories

Press Releases

Showing 1-35 of 224

First 1 2 3 4 5 6 7 Next Last

February

2/2/07	Abbott to Present at Merrill Lynch Health Care Conference
2/2/07	Psoriasis Patients Show Significant Improvement in Symptoms with Abbott's HUMIRA® in New Phase III Study

January

1/24/07	Abbott Reports Strong Fourth-Quarter Results and Record Operating Cash Flow in 2006
1/22/07	Abbott Nutrition to Host "The ZonePerfect® Bar" Music Series at 2007 Sundance Film Festival
1/18/07	Abbott to Sell Its Core Laboratory Diagnostics Business, Including Point of Care, to GE for $8.13 Billion
1/11/07	This New Year, Abbott, PHH Arval, and Environmental Defense Resolve to Address Climate Change Through Innovative Vehicle Fleet Program
1/11/07	Private-Label Version of Abbott's XIENCE™V Drug-Eluting Coronary Stent System Launches in Europe
1/8/07	Abbott m2000™ Instrument and Viral Load Tests for HIV-1 and HCV Approved in Canada

December

12/22/06	Abbott Employees Give Back This Holiday Season
12/21/06	Abbott Hosts Conference Call for Fourth-quarter and Full-year 2006 Earnings
12/20/06	Abbott to Present at 2007 JP Morgan Healthcare Conference
12/20/06	Abbott to Voluntarily Delist From NYSE Arca; Company Retains New York Exchange Listing
12/15/06	Abbott Completes Acquisition of Kos Pharmaceuticals, Inc.
12/14/06	Abbott Fund Supports Pioneering Malaria Education Program
12/13/06	Abbott Acquires a Majority of Shares of Kos Pharmaceuticals, Inc.
12/12/06	Abbott and Enanta Form Worldwide Alliance to Develop and Commercialize HCV Protease Inhibitors
12/8/06	Abbott Declares 332nd Consecutive Quarterly Dividend
12/6/06	Abbott to Participate in RBC Capital Markets Healthcare Conference
12/4/06	Abbott’s Acquisition of Kos Pharmaceuticals, Inc. Clears Antitrust Review
12/4/06	Abbott Introduces CE-Marked DNA Tests in Europe for the Detection of Chromosomal Abnormalities Associated With Leukemia
12/1/06	Earvin "Magic" Johnson and Abbott Announce Major Initiative on World Aids Day to Help Reduce New HIV/AIDS Infections Among African Americans

November

11/30/06	Abbott Again Recognized for Commitment to Environmental Excellence and Pollution Prevention
11/28/06	Children Affected by HIV/AIDS Around the World Bring Their Photographs and Stories to Chicago For the First Time
11/20/06	Abbott Nutrition's EAS® Brand to Enter into Relationship With the National Basketball Players' Association
11/14/06	Abbott Laboratories Commences Tender Offer for All Outstanding Shares of Kos Pharmaceuticals, Inc.
11/14/06	Abbott's HUMIRA® (adalimumab) Receives FDA Approval for Inhibiting Structural Joint Damage and Improving Physical Function in Patients with Psoriatic Arthritis
11/8/06	Abbott to Present at Credit Suisse Healthcare Conference
11/6/06	Abbott to Expand Presence in Lipid Management Market with Acquisition of Kos Pharmaceuticals
11/2/06	Abbott Named to Science Magazine's 2006 List of "Top Employers" in the Biotech and Pharmaceutical Industry
11/2/06	Abbott Fund, Baylor College of Medicine and the First Lady of Malawi Open the First Clinic for HIV-infected Children of Malawi

October

10/26/06	Abbott's Humira® (Adalimumab) Granted FDA Priority Review for the Treatment of Moderately to Severely Active Crohn's Disease
10/25/06	Dr. Aliade Chieffo Wins Fourth Annual Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award
10/25/06	Abbott Reports Positive Subset Results for XIENCE™ V in Tough-to-treat Diabetic Patients
10/24/06	Abbott Reports Initial Results from World's First Clinical Trial Featuring a Fully Bioabsorbable Drug-eluting Coronary Stent
10/23/06	New Phase III Data Shows Abbott's HUMIRA® (adalimumab) Induced Clinical Remissions in Patients with Crohn's Disease Who Lost Response To, or Were Intolerant To, Remicade® (infliximab)

First 1 2 3 4 5 6 7 Next Last

Narrow by Year

Narrow to Show

Home | Select a Country | Site Map | Contact Us | Privacy Policy | Terms of Use

Copyright © 2006, 2007 Abbott Laboratories. Abbott Park, Illinois, U.S.A.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott Laboratories, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott Laboratories, except to identify the product or services of the company.